Achilles Therapeutics plc (NASDAQ:ACHL) Short Interest Down 79.5% in January

Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) was the target of a significant decline in short interest in January. As of January 31st, there was short interest totalling 10,100 shares, a decline of 79.5% from the January 15th total of 49,200 shares. Currently, 0.0% of the company’s shares are sold short. Based on an […]

Leave a Reply

Your email address will not be published.

Previous post Boot Barn Holdings, Inc. (NYSE:BOOT) Director Gene Eddie Burt Sells 1,000 Shares
Next post AKITA Drilling (TSE:AKT.A) Shares Cross Below 200-Day Moving Average of $1.59